Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
17.03
0.00 (0.00%)
Aug 26, 2026, 4:00 PM EDT - Market closed
Theravance Biopharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 53.81 | 105.9 | -56.42 | -55.19 | 872.13 | -199.43 |
Depreciation & Amortization | 5.79 | 5.64 | 6.12 | 6.15 | 7.02 | 8.6 |
Loss (Gain) From Sale of Assets | - | 0.04 | 0.03 | 1.35 | -2.72 | 0.04 |
Asset Writedown & Restructuring Costs | - | - | 4.51 | - | - | - |
Loss (Gain) From Sale of Investments | -3.62 | -2.83 | -2.51 | -1.9 | - | - |
Stock-Based Compensation | 19.55 | 18.48 | 21.39 | 25.37 | 39.73 | 62.06 |
Other Operating Activities | -0.99 | -9.15 | -5.03 | 5.56 | -960.95 | -67.5 |
Change in Accounts Receivable | 1.54 | -27.1 | -0.97 | -0.69 | -2.72 | 1.8 |
Change in Accounts Payable | -1.02 | 0.33 | 0.75 | 0.01 | -1.61 | -3.53 |
Change in Unearned Revenue | - | - | - | -0.22 | -0.19 | -11.46 |
Change in Income Taxes | -15.45 | 10.48 | 9.91 | 1.1 | 63.95 | -0.19 |
Change in Other Net Operating Assets | -5.87 | 136.76 | 10.67 | -8.54 | -17.08 | -26.17 |
Operating Cash Flow | 53.74 | 238.54 | -11.54 | -27 | -186.99 | -207.86 |
Operating Cash Flow Growth | -78.07% | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.01 | -0.04 | -0.33 | -2.49 | -0.57 | -3.41 |
Sale of Property, Plant & Equipment | - | - | - | 1.51 | 4.58 | 0.01 |
Investment in Securities | -107.46 | -105.24 | 14.91 | -31.72 | 54.87 | 127.89 |
Other Investing Activities | - | - | -2.29 | - | 1,095 | - |
Investing Cash Flow | -107.47 | -105.28 | 12.28 | -32.7 | 1,154 | 124.49 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | - | - | - | -631.6 | -10.73 |
Net Debt Issued (Repaid) | - | - | - | - | -631.6 | -10.73 |
Issuance of Common Stock | 2.14 | 0.79 | 0.61 | 0.62 | 0.8 | 111.65 |
Repurchase of Common Stock | -10.58 | -4.03 | -3.1 | -199.55 | -132.28 | -9.06 |
Other Financing Activities | - | - | - | - | 4.28 | - |
Financing Cash Flow | -8.44 | -3.25 | -2.5 | -198.93 | -758.81 | 91.86 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -62.16 | 130.01 | -1.75 | -258.63 | 208.21 | 8.5 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 53.73 | 238.5 | -11.87 | -29.49 | -187.56 | -211.26 |
Free Cash Flow Growth | -78.05% | - | - | - | - | - |
Free Cash Flow Margin | 51.51% | 221.93% | -18.43% | -51.35% | -365.29% | -381.96% |
Free Cash Flow Per Share | 1.03 | 4.63 | -0.24 | -0.53 | -2.55 | -3.04 |
Levered Free Cash Flow | 5.3 | -4.12 | -42 | -12.22 | 24 | -115.85 |
Unlevered Free Cash Flow | 6.02 | -2.58 | -40.41 | -10.75 | 27.98 | -110.5 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | - | - | - | - | 22.24 | 39.03 |
Cash Income Tax Paid | 24.55 | 27.88 | 0.11 | 0.02 | 117.97 | -4.09 |
Change in Working Capital | -20.8 | 120.47 | 20.36 | -8.34 | 42.35 | -39.55 |